Molecular Diagnostics of Ageing and Tackling Age-related Disease

Area of Science:

• Gerontology and Biomedical Science
• Biomarker Discovery
• Computational Biology

Background:

• Increasing life expectancy necessitates a focus on health-span and preventing age-associated diseases.
• Current drug development approaches need innovation to target 'biological age' and delay aging-related conditions.
• Molecular and machine-learning technologies are advancing diagnostics for diseases like cancer and cardiovascular conditions.

Purpose of the Study:

• To review principles for developing biological age diagnostics.
• To explore the application of these diagnostics in drug discovery and development.
• To examine logistical and statistical considerations using Alzheimer's disease biomarkers as a case study.

Main Methods:

• Review of principles governing the development of aging diagnostics.
• Analysis of how biological age assays can be integrated into drug discovery pipelines.
• Case study analysis of biomarker activity in Alzheimer's disease research.

Main Results:

• Valid diagnostics of biological age, combined with disease biomarkers, can significantly impact drug discovery strategies.
• These diagnostics can optimize clinical trial recruitment and enhance healthy aging interventions.
• Alzheimer's disease research highlights the pharmaceutical industry's focus on age-related neurodegenerative disorders.

Conclusions:

• Biological age diagnostics offer a novel approach to combatting age-related diseases.
• Integrating these diagnostics into drug development can accelerate the discovery of effective therapies.
• Further research and validation are crucial for maximizing the potential of aging biomarkers in clinical practice.